Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Jellagen

Jellagen

A Med-Tech business manufacturing next generation collagen products sourced from Jellyfish


Presenter:

Andrew Mearns-Spragg, CEO

Jupiter Diagnostics

Jupiter Diagnostics

Developing a reader which allows anyone to perform blood tests quickly and affordably


Presenter:

Chris Ball, CEO

Kinomica

Kinomica

Kinomica Ltd is being established as a Research & Development company to commercialise unique, high-value products and services in the emerging field of stratified medicine for cancer


Presenter:

David Britton, CSO, Kinomica

Lein Applied Diagnostics

Lein Applied Diagnostics

Pioneering measurement devices and solutions for the healthcare and industrial markets


Presenter:

Daniel Daly, CEO

Lightpoint Medical

Lightpoint Medical

Dedicated to improving health outcomes for cancer patients through molecular-guided surgery


Presenter:

David Tuch, CEO

Linear Diagnostics

Linear Diagnostics

Developing a patent protected diagnostics platform based on the phenomenon of linear dichroism spectroscopy and a novel bionano-particle made using synthetic biology techniques


Presenter:

Matt Hicks, CTO

Macomics

Macomics

A drug discovery stage company focusing on the modulation of the tumour micro-environment


Presenter:

Gareth Blades, University of Edinburgh

MIP Diagnostics

MIP Diagnostics

Commercialising various forms of Molecularly Imprinted Polymers (MIPs)


Presenter:

Adrian Kinkaid, CEO

MuMac Ltd

MuMac Ltd

Creating innovative ophthalmic instruments for the rapid screening of eye diseases


Presenter:

Dennis Camilleri, CEO

mycoBiologics

mycoBiologics

Further information to follow


Presenter:

Fiona Rudkin, RSE Enterprise Fellow

Neuronostics

Neuronostics

Developing patient-specific software (BioEP) for epilepsy diagnosis decision support


Presenter:

John Terry, Neuronostics

NXR Biotechnologies

NXR Biotechnologies

Improving the translation of biotechnology innovation into commercial products that improve the quality of life


Presenter:

Alain Vertes, Managing Director